A high-profile New York infant nutrition expert with whom Care A2 Plus claims to have worked with says she rejected multiple approaches to consult for the company.
The University of Rochester Medical Center, where Bridget Young is employed, said she had “declined multiple requests from Care A2 to serve as a consultant, and she was not involved in any research the company may have conducted on the nutritional properties of its formula”.
“Dr Bridget Young has never worked with Care A2+ and provided no guidance regarding its development of infant formula products,” the spokesman said.
Care A2, in documents filed in the Federal Court as part of dispute with its distributor, said it had “worked with world-renowned expert, Dr Bridget Young from the University of Rochester, New York, and undertook research into the nutritional properties in infant formulas to enhance the existing Care A2+ formula that had been available in Australia since… 2020”.
Care A2 Plus was one of a small number of overseas infant formula producers allowed to import into the United States.
The distributor, Gensco Pharma, is suing Care A2 alleging it has lost $200 million in future profits over the failed partnership.
Gensco and Care A2 partnered in November amid a shortage of baby formula in the US, where the Australian company gained special access to a previously restricted market. The Biden administration allowed access for more overseas producers after a contamination issue at a major manufacturer created shortages last year.
However, the relationship quickly soured. In August, Gensco accused Care A2 of misleading or deceptive conduct, and breach of contract. Care A2 denies the allegations. Last week, the Australian company escalated the dispute,
Read more on afr.com